​

Funding Round

Seed Round - Siren Biotechnology

Seed Round - Siren Biotechnology

Investment Firm

Overview

Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.

Announced Date

May 17, 2023

Funding Type

Seed

Highlights

Location

United States, North America

Social

Investor Lead

Founders Fund

Founders Fund

Founders Fund is a debt and early_stage_venture and grant and late_stage_venture and private_equity and seed firm.

Lux Capital

Lux Capital

Lux Capital is a debt and early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorSavantus Ventures
Participant InvestorInnovation Endeavors
Participant InvestorLux Capital
Participant InvestorArtis Ventures (AV)
Participant InvestorFounders Fund

Round Details and Background

Siren Biotechnology raised an undisclosed amount on 2023-05-17 in Seed Round

Siren Biotechnology blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 17, 2023
Seed Round - Siren Biotechnology
6-undefined
Oct 27, 2023
Grant - Siren Biotechnology
1-4.0M
Apr 22, 2024
Seed Round - Siren Biotechnology
-19.6M
Jun 04, 2024
Grant - Siren Biotechnology
1-undefined

Recent Activity

There is no recent news or activity for this profile.